Compass Trial: A Randomised Controlled Trial of Primary Human Papillomavirus (HPV) Testing for Cervical Cancer Screening in Australia: Pilot Study
Not Applicable
Completed
- Conditions
- Human Papillomavirus (HPV)Cancer - Cervical (cervix)Cervical cancer
- Registration Number
- ACTRN12613001207707
- Lead Sponsor
- Roche Molecular Systems Inc. and
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 5001
Inclusion Criteria
Australian female resident of Victoria
Aged 25-64
Attending for routine cervical screening at a participating health care practice
Exclusion Criteria
Total hysterectomy (uterus and cervix)
Presence of symptoms for which cervical cancer must be excluded
Currently undergoing treatment for cervical pre-cancer, or cancer
Attending for follow-up of a prior cervical abnormality, including repeated test of cure procedures in which the woman has not yet been discharged back to routine screening
Known pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method